[MDGL] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
31-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 44.84%
YoY- 26.45%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -8,363 -8,347 -5,999 -7,749 -14,049 -3,379 -6,524 17.98%
Tax 100 0 0 142 -11,991 -110 0 -
NP -8,363 -8,347 -5,999 -7,749 -14,049 -3,379 -6,524 17.98%
Tax Rate - - - - - - - -
Total Cost 8,363 8,347 5,999 7,749 14,049 3,379 6,524 17.98%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS -0.68 -0.69 -0.50 -0.67 -1.59 -19.18 -37.03 -93.02%
EPS Diluted -0.68 -0.69 -0.50 -0.67 -1.59 -19.18 -37.03 -93.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.